Cargando…
Screening of the Pathogen Box reveals new starting points for anti-trypanosomal drug discovery
This study aimed to uncover new starting points for anti-trypansomal drug discovery through the screening of the Pathogen Box against Trypanosoma brucei brucei. Our study identified compounds 35, 39, 46, 53 and 56 whose activity and selectivity highlighted them as promising candidates with potential...
Autores principales: | Veale, Clinton G. L., Hoppe, Heinrich C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301270/ https://www.ncbi.nlm.nih.gov/pubmed/30647879 http://dx.doi.org/10.1039/c8md00319j |
Ejemplares similares
-
Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery
por: Duffy, Sandra, et al.
Publicado: (2017) -
Synthesis, Structure and In Vitro Anti-Trypanosomal Activity of Non-Toxic Arylpyrrole-Based Chalcone Derivatives
por: Zulu, Ayanda I., et al.
Publicado: (2020) -
Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening
por: Mackinnon, Sabrina R., et al.
Publicado: (2022) -
Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery
por: Maccesi, Martina, et al.
Publicado: (2019) -
The Discovery of the Human Trypanosome
por: Boyce, Robert, et al.
Publicado: (1902)